| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.05 |